Evidence map›Paper›PMID 36393921›Full record

ArticleJournal of public health in Africa2022

Restoring non-COVID-19 clinical research and surveillance in Oyo state, Nigeria during the SARS-CoV-2pandemic.

Veronica O Ogunleye, Okainemen P Oluwalusi, Oluwafemi Popoola, Aderemi Kehinde, Sarah Agbi, Ifeoluwa Akintayo, Ifiok Udofia, Folasade Bamidele, Temitope Alonge, Ondari D Mogeni and 4 more

Abstract read
In one paragraph

Article in Journal of public health in Africa, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Genomic Surveillance of SARS-CoV-2 in Ibadan, Oyo State, Nigeria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Veronica O OgunleyeSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.
Okainemen P OluwalusiSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.
Oluwafemi PopoolaSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.
Aderemi KehindeSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.
Sarah AgbiSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.
Ifeoluwa AkintayoDept. of Pharmaceutical Microbiology, Pharmacy, Univ. of Ibadan, Nigeria.
Ifiok UdofiaSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.
Folasade BamideleUniv. College Hospital, Ibadan, Nigeria.
Temitope AlongeUniv. College Hospital, Ibadan, Nigeria.
Ondari D MogeniInternational Vaccine Institute Seoul, Korea.
Olukemi AdekanmbiUniv. College Hospital, Ibadan, Nigeria.
Jolaade J AjiboyeDept. of Pharmaceutical Microbiology, Pharmacy, Univ. of Ibadan, Nigeria.
Florian MarksInternational Vaccine Institute Seoul, Korea.
Iruka N OkekeSevere Typhoid in Africa Project, College of Medicine, Univ. of Ibadan, Nigeria.

Funding

Medical Research Council MR/L00464X/1
6 · The paper itself

Abstract

Background: Many sub-Saharan African patients receive clinical care from extramurally-supported research and surveillance. Dur- ing the COVID-19 pandemic, pausing these activities reduces pa- tient care, surveillance, and research staff employment, increasing pandemic losses. In Oyo State, Nigeria, we paused a multi-country invasive salmonellosis surveillance initiative and a rural clinical bac- teriology project. Objective: Working with research partners raises health facility con- cerns about SARS-CoV-2 transmission risks and incurs infection pre- vention costs, so we developed and implemented re-opening plans to protect staff and patients and help health facilities deliver care. Methods: Our reopening plan included appointing safety and per- sonal protective equipment (PPE) managers from existing project staff cadres, writing new standard operating procedures, implement- ing extensive assessed training, COVID-19 testing for staff, procuring and managing PPE, and providing secondary bacteraemia blood culture support for COVID-19 patients in State isolation facilities. Results: Surveillance data showed that the pandemic reduced care access and negatively affected patient unsupervised antibacterial use. The re-opening plan repurposed human and material resources from national and international extramurally-supported programs to mitigate these effects on public health. Conclusions: A structured reopening plan restarted care, surveil- lance, and infection prevention and control.

Indexed as

Blood cultureCOVID-19Essential servicesSurveillance

Identifiers

PMID36393921
PMCPMC9664379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.